Recent News

• 03.19.2026 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
• 03.05.2026 - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
• 02.24.2026 - Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
• 02.19.2026 - Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results

Recent Filings

• 03.06.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2026 - 144 Report of proposed sale of securities